ArticleScientific reports2025
Visceral larva migrans among hospitalized patients in Poland: analysis of national hospital discharge data from 2014 to 2023.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visceral larva migrans (VLM) is a type of toxocariasis and is among the most widespread zoonotic parasitic infections of public health importance. This study aimed to describe the structure and epidemiological trends in hospitalization of patients with VLM in Poland (2014-2023). This population-based, retrospective study utilized hospitalization records of VLM patients in Poland obtained from the Nationwide General Hospital Morbidity Study. A total of 3559 hospital discharge records were assessed. The study group consisted of 1888 males (53% of all patients) and 1671 females (47%). Patients under 20 years of age accounted for 64.8% of all hospitalizations. The mean VLM hospitalization rate was estimated at 0.93 per 100,000. Significant differences were found between mean annual hospitalization rates in 2014-2019 and 2020-2023 (1.1 vs. 0.67 per 100,000, P < 0.001). A significantly greater share of VLM-related hospitalizations was observed in rural populations compared with urban counterparts (59.6% vs. 39.8%; P < 0.001). Hospitalizations of VLM patients primarily involved individuals under 20 years of age, males, and those living in rural areas. The reported data may be useful for comparative analyses in global contexts and suggest a need to promote higher public health standards for the monitoring and prevention of toxocariasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.